Atopic dermatitis (AD) is a common chronic inflammatory skin condition in children. In Asia, the prevalence of AD is increasing, which is largely attributed to environmental and socioeconomic factors including family income, parental education, lifestyle and metropolitan living. Current clinical guidelines recommend a stepped approach in the management of eczema in children, with treatment steps tailored to the severity of the eczema. To address the skin barrier dysfunction, skin hydration and the application of emollients is essential. There is evidence supporting the use of bleach baths as an antimicrobial therapy against Staphylococcus aureus. In patients in whom topical treatment fails, wet wrap therapy may be considered as a treatment option before considering systemic therapies. In the second part of this article, the economic burden of AD is addressed. AD not only negatively impacts the child's quality of life but also that of the whole family and is associated with a burden on health-care costs and society. AD in an infant will lead to frequent additional visits to the pediatrician, to additional and partially expensive treatment costs and, in rare cases, to hospitalization. It is thus of utmost importance to define efficient strategies to not only treat AD but also to decrease the risk of developing the disease.

1.
DaVeiga SP: Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 2012;33:227-234.
[PubMed]
2.
Peroni DG, Piacentini GL, Bodini A, et al: Prevalence and risk factors for atopic dermatitis in preschool children. Br J Dermatol 2008;158:539-543.
[PubMed]
3.
Asher MI, Keil U, Anderson HR, et al: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-491.
[PubMed]
4.
Odhiambo JA, Williams HC, Clayton TO, et al: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-1258.
[PubMed]
5.
Bleiker TO, Shahidullah H, Dutton E, Graham-Brown RA: The prevalence and incidence of atopic dermatitis in a birth cohort: the importance of a family history of atopy. Arch Dermatol 2000;136:274.
[PubMed]
6.
Matsuoka S, Nakagawa R, Nakayama H, et al: Prevalence of specific allergic diseases in school children as related to parental atopy. Pediatr Int 1999;41:46-51.
[PubMed]
7.
Nicolaou N, Siddique N, Custovic A: Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization. Allergy 2005;60:1357-1360.
[PubMed]
8.
von Mutius E: The environmental predictors of allergic disease. J Allergy Clin Immunol 2000;105(1 Pt 1):9-19.
[PubMed]
9.
Weber AS, Haidinger G: The prevalence of atopic dermatitis in children is influenced by their parents' education: results of two cross-sectional studies conducted in Upper Austria. Pediatr Allergy Immunol 2010;21:1028-1035.
[PubMed]
10.
Shaw TE, Currie GP, Koudelka CW, Simpson EL: Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011;131:67-73.
[PubMed]
11.
Asher MI, Montefort S, Bjorksten B, et al: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-743.
[PubMed]
12.
Wang XS, Tan TN, Shek LP, et al: The prevalence of asthma and allergies in Singapore; data from two ISAAC surveys seven years apart. Arch Dis Child 2004;89:423-426.
[PubMed]
13.
Tay YK, Kong KH, Khoo L, et al: The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 2002;146:101-106.
[PubMed]
14.
Tan TN, Lim DL, Lee BW, Van Bever HP: Prevalence of allergy-related symptoms in Singaporean children in the second year of life. Pediatr Allergy Immunol 2005;16:151-156.
[PubMed]
15.
Tan TN, Shek LP, Goh DY, et al: Prevalence of asthma and comorbid allergy symptoms in Singaporean preschoolers. Asian Pac J Allergy Immunol 2006;24:175-182.
[PubMed]
16.
Van Bever HP, Llanora G: Features of childhood atopic dermatitis. Asian Pac J Allergy Immunol 2011;29:15-24.
[PubMed]
17.
Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
[PubMed]
18.
Garnacho-Saucedo G, Salido-Vallejo R, Moreno-Gimenez JC: Atopic dermatitis: update and proposed management algorithm. Actas Dermosifiliogr 2013;104:4-16.
[PubMed]
19.
Kabashima K: New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013;70:3-11.
[PubMed]
20.
Flohr C, Johansson SG, Wahlgren CF, Williams H: How atopic is atopic dermatitis? J Allergy Clin Immunol 2004;114:150-158.
[PubMed]
21.
Bieber T: Atopic dermatitis. N Engl J Med 2008;358:1483-1494.
[PubMed]
22.
Cork MJ, Robinson DA, Vasilopoulos Y, et al: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006;118:3-21; quiz 22-23.
[PubMed]
23.
Harper JI, Ahmed I, Barclay G, et al: Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000;142:52-58.
[PubMed]
24.
Eller E, Kjaer HF, Host A, Andersen KE, Bindslev-Jensen C: Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol 2010;21(2 Pt 1):307-314.
[PubMed]
25.
Lewis-Jones S, Mugglestone MA: Management of atopic eczema in children aged up to 12 years: summary of NICE guidance. Br Med J 2007;335:1263-1264.
[PubMed]
26.
Arkwright PD, Motala C, Subramanian H, et al: Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract 2013;1:142-151.
[PubMed]
27.
Rubel D, Thirumoorthy T, Soebaryo RW, et al: Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol 2013;40:160-171.
[PubMed]
28.
Kong HH, Oh J, Deming C, et al: Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012;22:850-859.
[PubMed]
29.
American Academy of Allergy, Asthma and Immunology: Bleach Bath Recipe for Skin Conditions. http://www.aaaai.org/conditions-and-treatments/library/allergy-library/bleach-bath-recipe-for-skin-conditions.aspx.
30.
Huang JT, Abrams M, Tlougan B, et al: Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009;123:e808-e814.
[PubMed]
31.
Nicol NH, Boguniewicz M, Strand M, Klinnert MD: Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract 2014;2:400-406.
[PubMed]
32.
Su JC, Kemp A, Varigos G, Nolan T: Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997;76:159-162.
[PubMed]
33.
Su JC, Prescott S, Sinn J, Tang M, Smith P, Heine RG, Spieldenner J, Iskedjian M: Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia. J Med Econ 2012;15:1064-1077.
[PubMed]
34.
Kang KH, Kim K-W, Kim DH: Utilization pattern and cost of medical treatment and complementary alternative therapy in children with atopic dermatitis. Pediatr Allergy Respir Dis 2012;22:27-36.
35.
Ngamphaiboon J, Kongnakorn T, Detzel P, et al: Direct medical costs associated with atopic diseases among young children in Thailand. J Med Econ 2012;15:1025-1035.
[PubMed]
36.
Bhanegaonkar A, Horodniceanu EG, Gonzalez RRH, et al: Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in at-risk urban Filipino infants. Value Health Regional Issue 2014;3:124-135.
[PubMed]
37.
Bhanegaonkar A, Horodniceanu EG, Ji X, Detzel P, Botteman MF: Burden of Atopic Dermatitis in Indonesia, Malaysia, and Singapore: Estimates from a Mathematical Model. Poster presented at ISPOR Asia/Pacific 2014. Value Health 2014;17:A778.
You do not currently have access to this content.